Sarah L. Norris

Protective Antigen (PA) and Toxin Neutralization (TNA) Antibody Patterns in Anthrax Vaccinees Undergoing Serial Plasmapheresis (2005)

Pitman, Phillip R., Leitman, Susan F., Barrera-Oro, Julio G., Norris, Sarah L., Marano, Nina M., Ranadive, Manmohan V., ...

Recipients of licensed anthrax vaccine (AVA, Biothrax ) could serve as a source of hyperimmune plasma and immunoglobulin for therapy and prophylaxis. We examined serum antibody patterns during serial...

Interleukin-12 Induces a Th1-Like Response to Burkholderia mallei and Limited Protection in BALB/c Mice (1998)

Amemiya, Kei, Meyers, Jennifer L., Trevino, Sylvia R., Chanh, Tran C., Norris, Sarah L., Wagg, David M.

We evaluated the effect of interleukin (IL)-12 on the immune response to Burkholderia mallei in BALB/c mice. Mice were vaccinated with non-viable B. mallei cells with or without IL-12. There was a...

An Assessment of Health Status Among Medical Research Volunteers Who Served in the Project Whitecoat Program at Fort Detrick, Maryland (1998)

Pittman, Phillip R., Norris, Sarah L., Coonan, Kevin M., McKee, Jr, Kelly T.

Between 1954 and 1973, more than 2000 men entering military service as conscientious objectors participated in Project Whitecoat as medical research volunteers for the Army's biological warfare...

Interleukin-12 Induces a Th1-like Response to Burkholderia mallei and Limited Protection in BALB/c Mice (1998)

Amemiya, Kei, Meyers, Jennifer L., Trevino, Sylvia R., Chanh, Tran C., Norris, Sarah L., Waag, David M.

We evaluated the effect of interleukin (IL)-12 on the immune response to Burkholderia mallei in BALB/c mice. Mice were vaccinated with non-viable B. mallei cells with or without IL-12. There was a...

Patterns of Antibody Response in Humans to the Anthrax Vaccine Adsorbed (AVA) Primary (six-dose) Series (1998)

Pittman, Phillip R., Norris, Sarah L., Oro, Julio G., Bedwell, David, Cannon, Timothy L., McKee, Kelly T.

The antibody profile during and after the six-dose primary vaccination series with anthrax vaccine adsorbed (AVA, BiothraxTM)was characterized in 86 human volunteers. Ninety-three percent of...

Protective Antigen and Toxin Neutralization Antibody Patterns in Anthrax Vaccinees Undergoing Serial Plasmapheresis

Pittman, Phillip R., Leitman, Susan F., Oro, Julio G. Barrera, Norris, Sarah L., Marano, Nina M., Ranadive, Manmohan V., ...

Recipients of licensed anthrax vaccine (AVA; Biothrax) could serve as a source of hyperimmune plasma and immunoglobulin for therapy and prophylaxis. We measured serum antibodies during serial weekly...

Protective Antigen and Toxin Neutralization Antibody Patterns in Anthrax Vaccinees Undergoing Serial Plasmapheresis

Pittman, Phillip R., Leitman, Susan F., Oro, Julio G. Barrera, Norris, Sarah L., Marano, Nina M., Ranadive, Manmohan V., ...

Recipients of licensed anthrax vaccine (AVA; Biothrax) could serve as a source of hyperimmune plasma and immunoglobulin for therapy and prophylaxis. We measured serum antibodies during serial weekly...

Determination of Antibiotic Efficacy against Bacillus anthracis in a Mouse Aerosol Challenge Model▿

Heine, Henry S., Bassett, Jennifer, Miller, Lynda, Hartings, Justin M., Ivins, Bruce E., Pitt, M. Louise, ...

An anthrax spore aerosol infection mouse model was developed as a first test of in vivo efficacy of antibiotics identified as active against Bacillus anthracis. Whole-body, 50% lethal dose (LD50)...